MedPath

A Study to Compare SB11 (Proposed Ranibizumab Biosimilar) to Lucentis in Subjects With Neovascular Age-related Macular Degeneration (AMD)

Phase 3
Completed
Conditions
Age-Related Macular Degeneration
Interventions
Registration Number
NCT03150589
Lead Sponsor
Samsung Bioepis Co., Ltd.
Brief Summary

This is a randomised, double-masked, parallel group, multicentre study to evaluate the efficacy, safety, pharmacokinetics and immunogenicity of SB11 compared to Lucentis® in subjects with neovascular AMD.

Detailed Description

Subjects will be randomised in a 1:1 ratio to receive either SB11 or Lucentis® (administered via intravitreal (ITV) 0.5 mg every 4 weeks). Investigational Products (IP) (SB11 or Lucentis®) will be administered up to Week 48, and the last assessment will be done at Week 52.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
705
Inclusion Criteria
  1. Age ≥ 50 years
  2. Newly diagnosed, active subfoveal choroid neovascularisation (CNV) lesion secondary to AMD in the study eye
  3. BCVA of 20/40 to 20/200 in the study eye
  4. Written informed consent form
Exclusion Criteria
  1. Any previous ITV anti-vascular endothelial growth factor (anti-VEGF) treatment to treat neovascular AMD in either eye
  2. Presence of CNV in either eye due to other causes, such as ocular histoplasmosis, trauma, multifocal choroiditis, angioid streaks, history of choroidal rupture or pathologic myopia
  3. Any concurrent macular abnormality other than AMD in the study eye

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SB11 (Proposed ranibizumab biosimilar)SB11 (Proposed ranibizumab biosimilar)-
Lucentis (ranibizumab)Lucentis (ranibizumab)-
Primary Outcome Measures
NameTimeMethod
Change From Baseline in Best Corrected Visual Acuity (BCVA)Baseline and Week 8

The VA was assessed using original series ETDRS charts or 2702 series number charts.

Change From Baseline in Central Subfield Thickness (CST)Baseline and Week 4

The average retinal thickness in the central 1-mm area in the ETDRS grid (CST) was evaluated using (Optical Coherence Tomography) OCT

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (74)

Southeast Retina Center

🇺🇸

Augusta, Georgia, United States

Retina Vitreous Surgeons fo Central NY, PC

🇺🇸

Syracuse, New York, United States

Charleston Neuroscience Institute

🇺🇸

Ladson, South Carolina, United States

Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego, Klinika Okulistyki

🇵🇱

Wrocław, Wroclaw, Poland

Centrum Diagnostyki i Mikrochirurgii Oka LENS

🇵🇱

Olsztyn, Poland

Retina Associates of Cleveland

🇺🇸

Middleburg Heights, Ohio, United States

Bristol Eye Hospital

🇬🇧

Bristol, United Kingdom

Federal State Budget Scientific Institution "Scientific Research Institute of Eye Diseases"

🇷🇺

Moscow, Russian Federation

Frimley Park Hospital

🇬🇧

Frimley, United Kingdom

Specjalistyczna Praktyka Lekarska Prof. E. Wylęgała

🇵🇱

Katowice, Poland

Deputy Director of The S.N.Fyodorov Eye Microsurgery State Institution Complex

🇷🇺

Moscow, Russian Federation

Federal State Educational Institution of High Professional Education "1st Saint-Petersburg State Medical University n.a. academic I.P. Pavlov" of Ministry of Healthcare of Russian Federation

🇷🇺

Saint Petersburg, Russian Federation

Universitaetsklinikum Bonn

🇩🇪

Bonn, Germany

Queens University Belfast

🇬🇧

Belfast, United Kingdom

Szpital Specjalistyczny im Sokołowskiego Oddzial Okulistyczny

🇵🇱

Wałbrzych, Walbrzych, Poland

Oftalmika ul. Modrzewiowa 15 85-631 Bydgoszcz

🇵🇱

Bydgoszcz, Poland

Federal State Autonomous Institution "Intersectoral research and technical complex "Eye Microsurgery" named after acad. S.N. Fyodorov" of Ministry of Health of Russian Federation

🇷🇺

Novosibirsk, Russian Federation

Moorfields Eye Hospital

🇬🇧

London, United Kingdom

SBEI HPE "Samara State Medical University" of the MoH of the RF

🇷🇺

Samara, Russian Federation

Raj K. Maturi, MD, PC

🇺🇸

Indianapolis, Indiana, United States

Retina Consultants of Houston

🇺🇸

Houston, Texas, United States

Retina consultants San Diego

🇺🇸

Poway, California, United States

Retina Consultants of Hawaii

🇺🇸

'Aiea, Hawaii, United States

Retina Associates of Western NY

🇺🇸

Rochester, New York, United States

LIVR

🇺🇸

Great Neck, New York, United States

Retina Research Institute of Texas

🇺🇸

Abilene, Texas, United States

University Hospital Hradec Kralove

🇨🇿

Hradec Králové, Czechia

University Hospital Olomouc

🇨🇿

Olomouc, Czechia

Fakultni nemocnice Kralovske Vinohrady

🇨🇿

Praha 10, Czechia

Augenärzte am St. Franziskus-Hospital Münster

🇩🇪

Münster, Munster, Germany

Axon Clinical s.r.o.

🇨🇿

Praha 5, Czechia

Uni Düsseldorf

🇩🇪

Duesseldorf, Germany

University Medical Center, Freiburg

🇩🇪

Freiburg, Germany

University of Tuebingen STZ eyetrial at the Department of Ophthalmology

🇩🇪

Tuebingen, Germany

TU Munich

🇩🇪

Muenchen, Germany

MVZ ADTC Siegburg GmbH

🇩🇪

Siegburg, Germany

Budapest Retina Associates Ltd.

🇭🇺

Budapest, Hungary

Jahn Ferenc Del-pesti Korhaz es Rendelointezet

🇭🇺

Budapest, Hungary

Peterfy Sandor utcai Korhaz-Rendelointezet es Baleseti Kozpont

🇭🇺

Budapest, Hungary

Semmelweis Egyetem Szemeszeti Klinika

🇭🇺

Budapest, Hungary

Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont

🇭🇺

Szeged, Hungary

Shankara Netralaya

🇮🇳

Chennai, India

Aravind Eye Hospital

🇮🇳

Coimbatore, India

Shroff eye Hospital

🇮🇳

Mumbai, India

Pusan National University Hospital

🇰🇷

Busan, Korea, Republic of

Asan Medical Center

🇰🇷

Seoul, Korea, Republic of

University Hospital Brno

🇨🇿

Brno, Czechia

Retina Consultants of Southern Colorado

🇺🇸

Colorado Springs, Colorado, United States

Retina Consultants

🇺🇸

Fort Myers, Florida, United States

Austin Restina Associates

🇺🇸

Austin, Texas, United States

Black Hills Regional Eye Institute

🇺🇸

Rapid City, South Dakota, United States

Retina Center of New Jersey, LLC

🇺🇸

Bloomfield, New Jersey, United States

University Hopsital Ostrava

🇨🇿

Ostrava, Czechia

Markusovszky Egyetemi Oktatokorhaz

🇭🇺

Szombathely, Hungary

NJ Retina

🇺🇸

Toms River, New Jersey, United States

Long Island Vitreoretinal Consultants

🇺🇸

Hauppauge, New York, United States

Uni Göttingen

🇩🇪

Goettigen, Germany

Retina consultants of Houston

🇺🇸

Conroe, Texas, United States

Klinikum Chemnitz gGmbH

🇩🇪

Chemnitz, Germany

Ganglion Orvosi Kozpont

🇭🇺

Pécs, Pecs, Hungary

Charite

🇩🇪

Berlin, Germany

Magyar Honvedseg Egeszsegugyi Kozpont

🇭🇺

Budapest, Hungary

Bajcsy-Zsilinszky Korhaz es Rendelointezet

🇭🇺

Budapest, Hungary

Yeungnam University Hospital

🇰🇷

Daegu, Korea, Republic of

Debreceni Egyetem Klinikai Kozpont, Szemklinika

🇭🇺

Debrecen, Hungary

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

Seoul National University Bundang Hospital

🇰🇷

Seongnam-si, Korea, Republic of

Samsung Medical Center

🇰🇷

Seoul, Korea, Republic of

The Catholic University of Korea, Seoul St. Mary's Hospital

🇰🇷

Seoul, Korea, Republic of

"State Autonomous Iinstitution of Healthcare "Republican clinical ophthalmological hospital of MoH of Republic of Tatarstan"

🇷🇺

Kazan, Russian Federation

PGIMER

🇮🇳

Chandigarh, India

Regional Institute of Opthalmology

🇮🇳

Trivandrum, India

Medilink Hospital

🇮🇳

Ahmedabad, India

Centrum Medyczne UNO-MED.

🇵🇱

Kraków, Poland

© Copyright 2025. All Rights Reserved by MedPath